Thermo Fisher Scientific, the global leader in scientific services, has been granted FDA approval for its Ion Torrent™ Oncomine™ Dx Target Test as a companion diagnostic to select patients suitable for treatment with Servier Pharmaceuticals, LLC’s...
Ionis Pharmaceuticals, Inc. revealed that the Committee for Medicinal Products for Human Use (CHMP) in the European Union (EU) has recommended the approval of Ionis' and AstraZeneca's Wainzua (eplontersen) for treating hereditary transthyretin...
Oculis Holding AG (Oculis) has sped up the enrollment of patients for the phase 3 DIAMOND clinical trials of OCS-01 eye drops in DME and expanded the DIAMOND programme committees with leading retina specialists worldwide. Significant advancement...
The anti-diabetes market has tripled to almost Rs 17,000 crore, and the cardiac market has more than doubled to nearly Rs 30,000 crore from its 2014 levels of Rs 5,000 crore and Rs 10,000 crore, respectively. Sheetal Sapale, vice president of...
Akums Drugs & Pharmaceuticals, a CDMO, has entered into a strategic partnership with Triple Hair Group, a Canadian company focusing on creating new remedies for androgenic alopecia. This is specifically for the exclusive licensing of their...
Boston Scientific Corporation, a leading global medical technology company, stated it got approval from the US FDA for the Farawave NAV Ablation Catheter and FDA 510(k) clearance for the Faraview Software, both used in treating paroxysmal atrial...
Alembic Pharmaceuticals Ltd announced that it has obtained approval from the US health regulator for its generic Diltiazem Hydrochloride extended-release capsules, which are used for treating hypertension. The company stated that the USFDA has...
Indian companies supply 40% of the world's generic medicines, showcasing India's important role in global healthcare. Dr. Jitendra Kumar, Managing Director of BIRAC, stated that the biotechnology industry in the country is experiencing impressive...
TuHURA Biosciences, a company in phase 3 of registering immune-oncology, is creating new technologies to tackle resistance to cancer immunotherapy. They have finished the merger with Kintara Therapeutics, Inc. and are now called TuHURA Biosciences...
Krishna Institute of Medical Sciences (KIMS), a hospital chain in Hyderabad, announced that it has signed an agreement with Wipro GE Healthcare to acquire medical technology and services worth up to Rs 700 crore. The memorandum of understanding...
, CDSCO.jpg)
